MIR558: A Potential Drug Target and Biomarker (G693143)
MIR558: A Potential Drug Target and Biomarker
MIR558 (MIRN558), a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and diverse functions make it an attractive target for researchers to investigate.
MIR558 is a small non-coding RNA molecule that is expressed in various tissues and cells of the body. It is composed of 19 non-coding RNA bases and has a unique structure that consists of a core-peripheral structure. The core of MIR558 consists of a stem-like structure that is surrounded by a series of loops and tail-like regions. This unique structure allows MIR558 to interact with various proteins and have diverse functions in different cell types.
One of the most significant functions of MIR558 is its role in cell signaling. MIR558 has been shown to play a role in various signaling pathways, including cell proliferation, differentiation, and survival. It has been shown to promote the growth and survival of cancer cells , and it has also been shown to inhibit the growth and survival of healthy cell lines. These findings suggest that MIR558 may be a promising drug target for cancer treatment.
MIR558 has also been shown to play a role in the regulation of gene expression. It has been shown to interact with various proteins, including tyrosine kinase, which are involved in cell signaling. cell signaling, immune response, and inflammation.
MIR558 has also been shown to have unique functions in the development and progression of diseases. For example, MIR558 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. in the development of cancer, including breast and ovarian cancer. These findings suggest that MIR558 may be a promising biomarker for detecting and predicting the development of these diseases.
In addition to its role in cell signaling and gene regulation, MIR558 has also been shown to have unique functions in the regulation of cell adhesion. It has been shown to play a role in the formation of tight junctions, which are responsible for maintaining the integrity of the intercellular space and are involved in various signaling pathways. These findings suggest that MIR558 may be a promising drug target for diseases that are characterized by the disruption of cell adhesion, such as cancer.
MIR558 has also been shown to have unique functions in the regulation of cellular processes that are involved in the development and progression of diseases. For example, MIR558 has also been shown to play a role in the regulation of cell division, which is involved in the development and progression of cancer. It has also been shown to play a role in the regulation of cell apoptosis, which is involved in the elimination of damaged or dysfunctional cells. These findings suggest that MIR558 may be a promising drug target for diseases that are characterized by the disruption of cellular processes that are involved in the development and progression of cancer.
In conclusion, MIR558 is a unique non-coding RNA molecule that has been shown to play a role in various signaling pathways and cellular processes that are involved in the development and progression of diseases. Its unique structure and diverse functions make it an attractive target for researchers to investigate. Further studies are needed to determine the full range of functions of MIR558 and its potential as a drug target.
Protein Name: MicroRNA 558
The "MIR558 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR558 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070
